Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03426267 · ClinicalTrials.gov registry record · Phase 3
Evaluation of Efficacy and Safety of SDN-037
A Phase 3 study, sponsored by Sun Pharma Advanced Research Company Limited.
- Completed
- Registry status
- Phase 3
- Development phase
- 325
- Enrollment target
NCT03426267 is a Phase 3 study that has completed, run by Sun Pharma Advanced Research Company Limited. The registered enrollment target is 325 participants.
The verdict
NCT03426267, a Phase 3 study, has completed, sponsored by Sun Pharma Advanced Research Company Limited.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 325 participants
- Enrollment target
Study Summary
The efficacy and safety of SDN-037 twice daily will be evaluated and compared with vehicle for the treatment of inflammation and pain associated with ocular surgery.
Interventions
- DRUG Placebo
- DRUG SDN-037
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2018-09-28 |
| Est. Completion | 2020-03-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03426267
The ClinicalTrials.gov registry entry for NCT03426267 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sun Pharma Advanced Research Company Limited, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03426267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03426267 about?
NCT03426267 is a clinical study titled "Evaluation of Efficacy and Safety of SDN-037". The efficacy and safety of SDN-037 twice daily will be evaluated and compared with vehicle for the treatment of inflammation and pain associated with ocular surgery.
What is the current status of trial NCT03426267?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 325 participants. The study started on 2018-09-28. Estimated completion is 2020-03-05.
What interventions are being tested in trial NCT03426267?
The interventions under investigation include: Placebo (DRUG), SDN-037 (DRUG).
Who is sponsoring clinical trial NCT03426267?
This trial is sponsored by Sun Pharma Advanced Research Company Limited, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.